An analogue of "HIV-1 protease" was designed in which the ability to donate important water-mediated hydrogen bonds to substrate was precisely and directly deleted. Chemical ligation of unprotected peptide segments was used to synthesize this "backbone-engineered" enzyme. The functionally relevant amide -CONH-linkage between residues Gly49-le50 in each flap of the enzyme was replaced by an isosteric thioester -COS-bond. The backbone-engineered enzyme had normal substrate specificity and affinity (Kn). However, the catalytic activity (kct) was reduced -3000-fold compared to the native amide bond-containing enzyme. Inhibition by the reduced peptide bond substrate analogue MVT-101 was unaffected compared with native enzyme. By contrast, the normally tight-binding hydroxyethylamine inhibitor JG-365 bound to the backbone-engineered enzyme with an -2500-fold reduction in affinity. The reduced catalytic activity of the -Gly49-
the native amide bond-containing enzyme. Inhibition by the reduced peptide bond substrate analogue MVT-101 was unaffected compared with native enzyme. By contrast, the normally tight-binding hydroxyethylamine inhibitor JG-365 bound to the backbone-engineered enzyme with an -2500-fold reduction in affinity. The reduced catalytic activity of the -Gly49-*(COS)-lles-backbone-engineered enzyme analogue provides direct experimental evidence to support the suggestion that backbone hydrogen bonds from the enzyme flaps to the substrate are important for the catalytic function of the HIV-1 protease.
The mature proteins packaged within virions of the human immunodeficiency virus (HIV) are initially translated as the large precursor polyproteins gag and gag-pol. The role of the aspartic proteinase from HIV-1 ("HIV-1 protease") is to proteolytically process these translation products to give functional core proteins and the enzymes required for viral replication (1) .
In contrast to the single-chain nonviral aspartic proteinases such as pepsin, the HIV-1 protease has been characterized as a homodimeric molecule (2) . The monomer of the HIV-1 protease consists of 99 amino acid residues, and each monomer contributes one ofthe two conserved active-site aspartyl residues. X-ray crystallography has revealed the HIV-1 protease to be structurally related to the larger two-domain pepsin-like aspartic proteinases (2) (3) (4) . Despite the difference in quaternary structure, the similarity between the two types of aspartic proteinases is immediately obvious upon superposition of the molecular structures (2) .
An important structural feature of the aspartic proteinases is the 3-hairpin region known as the "flap". The flap is a mobile surface feature, characterized by high thermal factors in the crystal structures of the free enzyme (4) . The homodimeric HIV-1 protease molecule possesses two flaps, in contrast to the single flap of the pepsin-like proteinases (2) . Upon binding inhibitor (and presumably substrate), the flap(s) undergoes movement to interact with and lock the substrate into the active site, simultaneously desolvating the enzyme-bound ligand (4, 5) . Potentially the most significant and intriguing difference between the HIV-1 protease and nonviral aspartic proteinases is in the mode of interaction of the tip of the flap(s) with
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. the inhibitor. In crystal structures of both types of aspartic proteinases, hydrogen bonds are observed between the protein backbone near the tip of the flap(s) and the carbonyl oxygens flanking the pseudoscissile bond of bound, substrate-based peptide inhibitor. These flap-substrate hydrogen bonds have been implicated in an out-of-plane distortion of the scissile amide bond, thereby facilitating attack by a nucleophilic water molecule (6) (7) (8) (9) . However, while the amide -NH-of peptide bonds near the tip of the single flap in pepsin-like proteinases donate hydrogen bonds directly to the substrate (6, 10) , the corresponding hydrogen bonds in the HIV-1 protease are contributed one from each flap and appear to be mediated by a specific, tetrahedrally coordinated internal water molecule, water 301 (5), poised between the flaps and the inhibitor (Fig. 1A ). This water molecule (which is not the nucleophilic water) has been observed in all HIV-1 protease enzyme-inhibitor cocrystal structures so far reported (11) . This raises the question, are the watermediated hydrogen bonds from the flaps to substrate/ inhibitor important to the enzyme activity of the HIV-1 protease?
We sought to experimentally address the role of the hydrogen bonds between enzyme flaps and the substrate in the mode of action of the HIV-1 protease. An enzyme analogue was designed in which the protein backbone would lack the ability to donate the flap hydrogen bonds observed in the x-ray crystal structure (5, 7, 8) . A sulfur atom specifically substitutes for an -NH-in a single peptide bond in the backbone of each flap (Fig. 1B) . This could be done with surgical precision using the chemical dovetailing approach (13) , which creates a backbone analogue structure at the ligation site. This report describes the synthesis and enzymatic properties ofa "backbone-engineered" analogue ofthe HIV-1 protease, in which the functionally relevant amide bond between residues Gly49 and 11e50 has been replaced by a thioester linkage. Guanidine hydrochloride was added to the pooled HPLC fractions, and the solution was dialyzed against decreasing concentrations of guanidine hydrochloride in dialysis buffer (25 mM Mes, pH 5.5/20% glycerol). The concentration of the folded protein was determined by absorbance at 280 nm of a dilute sample in 6 M guanidine hydrochloride using a molar extinction coefficient of 25,000 M-lcm-1 (20) . Typically, 0.35 mg of folded enzyme analogue was obtained, reflecting a yield of 4.5% based on the starting peptide segments. Folded enzyme was stored in dialysis buffer at 4°C, and under these conditions, no significant autolytic or chemical degradation of the enzyme was observed after a period of 4 weeks.
MATERIALS AND METHODS
The molecular mass of folded [(COS)49-50]HIV-1 protease dimer (hereafter referred to as backbone-engineered HIV-1 PR) was investigated by gel filtration using a Pharmacia Superdex 75 column, running at 0.5 ml/min with 100 mM NaOAc/0.5 M NaCl, pH 5.3, as the mobile phase. The concentration of enzyme as loaded onto the column was 0.4 ,uM, and protein peaks were detected by fluorescence at 335 nm (excitation 280 nm). The observed molecular mass of backbone-engineered HIV-1 PR was determined from a plot of log(molar mass) versus retention time, calibrated by coinjection of reference proteins.
Enzymatic Properties. Comparison of the substrate specificity of backbone-engineered HIV-1 PR with that of "native amide" enzymet was assessed by the cleavage of two synthetic peptides spanning the p17/p24 and p24/pl5 cleavage sites in the viral gag-pol protein (22) . The p17/p24 peptide (500 ,uM) was incubated with backbone-engineered HIV-1 PR (35 nM) at 37°C in a pH 5.5 assay buffer containing 50 mM HOAc, 50 mM Mes, 100 mM Tris, 10% glycerol, and bovine serum albumin at 0.5 mg/ml, with the ionic strength adjusted to 1.0 by the addition of NaCl. Formation of cleavage products over several days was followed by HPLC, and their identity was confirmed by MS anism and results in the inversion of stereochemical configuration at the reaction center (15) . Thus the initial stereochemistry at the a carbon of BrMV corresponded to that of a D-amino acid and gave the same configuration as an L-amino acid after ligation (Fig. 2) . The stereochemistry of the f8 carbon in the BrMV residue was unaffected by the ligation reaction and remains equivalent to that of the f3 carbon in L-isoleucine. Ligation of the two peptide segments led to modest yields of the target molecule, and subsequent purification by HPLC followed by folding of the synthetic monomer gave enzymatically active homodimer.
The homogeneity and covalent structure of the synthetic [(COS)49-50]HIV-1 protease monomer were confirmed by analytical HPLC and MS: observed molecular mass = 10,769 Da (calculated = 10,771 Da, average isotope composition). The molecular mass of the folded backbone-engineered HIV-1 PR, as determined by gel filtration under native conditions, was found to be consistent with that of a homodimer (observed molecular mass = 21.5 ± 0.5 kDa; calculated = 21.5 kDa). At the concentration of enzyme used (0.4 ,M), there was no detectable peak corresponding to monomeric protein (detection limit c 5 mol %). Injection of an identical amount of folded native amide enzyme gave a peak of the same area at the same elution time. This is strong evidence that the backbone-engineered [(COS)49-50]HIV-1 PR has folded to a native tight homodimeric threedimensional structure.
Enzymatic activity and substrate specificity of backboneengineered HIV-1 PR were confirmed by cleavage of a fluorogenic substrate (23) , as well as by cleavage of known synthetic peptide analogues of the p17/p24 and p24/plS junctions in the viral gag-pol polyprotein (26) . As anticipated, the p17/p24 peptide was cleaved at the Tyr-Pro site, whereas the p24/p15 peptide was cleaved at the expected Met-Met and Leu-Ala sites (Fig. 3) . No additional cleavage sites were observed in any of these peptides upon prolonged incubation for several days. These cleavages showed normal characteristics of an enzyme-catalyzed reaction and were at the identical sites for native amide enzyme (26) and for the processing observed in virus maturation in vivo (1) . The backbone-engineered protein is thus an enzyme with the same substrate specificity as native enzyme.
Calculation of the kinetic parameters for cleavage of fluorogenic substrate by the backbone-engineered HIV-1 PR (Fig. 3) The peptide RRSNQVSQNY-PIVQNIQGRR, a synthetic analogue of the matrix/capsid (MA/CA) processing site in the HIV-1 gag translation product was progressively cleaved over 72 hr at pH 5.5 by the analogue enzyme to give the fragments PIVQNIQGRR (peak 1) and RRSNQVSQNY (peak 2), resulting from specific cleavage at the Tyr-Pro peptide bond. (Lower) Similarly, the peptide GHKARVL-AEAMSQVTN-SATIM-MQRGNFRNQRK, a synthetic analogue of the HIV-1 capsid-nucleocapsid (CA/NC) processing sites, was progressively cleaved over 72 hr at pH 5.5 to yield GHKARVLAEAMSQVTNSA-TIM (peak 1), AEAMSQVTNSATIMMQRGNFRNQRK (peak 2), AEAMSQVTNSATIM (peak 3), GHKARVL (peak 4), and MQRGNFRNQRK (peak 5). These fragments result from specific cleavage at the Leu-Ala and Met-Met peptide bonds. For both substrates, no other cleavages were observed. All cleavages were identical to those observed with native amide HIV-1 protease and were the same as the processing events in viral maturation in vivo. the reduction in activity is not a consequence of some unanticipated more drastic perturbation in structure awaits verification by crystallography or other direct means.
Inhibition (Fig. 3) by the reduced amide bond peptide inhibitor MVT-101 was found to be similar for the backbone- be 590 nM. Thus, JG-365 is =2500-foldt less potent against the backbone-engineered HIV-1 PR. This figure is remarkably similar to the reduction in the rate of substrate hydrolysis by the backbone-engineered HIV-1 PR (3000-fold) and again is consistent with the effect that would be expected from the loss of two hydrogen bonds. It is not surprising that MVT-101 was found to be an equally effective inhibitor of the backbone-engineered HIV PR and the native amide enzyme, given that both enzymes have equal affinity for substrate (as indicated by the Km values). The onus then is to explain the reduced potency of JG-365. Inspection of the crystal structures of complexes of these two inhibitors with the HIV-1 protease offers one *The exact value will depend on Ki for JG-365 under the same assay conditions used in this study. Additionally, the JG-365 used in this work lacked the C-terminal methyl ester, although this is known to have negligible effect on its potency (29) . possible explanation (5, 7, 30 In proteolytic enzymes, the strain mechanism theory has generally been proposed to assist in catalysis by distortion of the scissile peptide bond from planarity, resulting in a reduction of its double bond character and making the carbon atom susceptible to attack by the nucleophilic water (6) (7) (8) (9) 31) . This assumes that the slow step in catalysis is the formation of the tetrahedral intermediate. However, recent detailed kinetic analysis of the HIV-1 protease indicates that the ratedetermining step in catalysis is not the formation of the tetrahedral intermediate but rather breakdown of the tetrahedral intermediate into the cleavage products (32, 33) . Hydrogen bonds from the enzyme flaps to the P2 and P1 carbonyls of the substrate would then serve to lower the activation barrier of the rate-determining step, perhaps by correctly orienting the lone-pair orbital of the leaving group nitrogen. The effect of deleting these hydrogen bonds would be to retard breakdown of the tetrahedral intermediate (Fig. 4) .
This hypothesis correlates well with the observed inhibition data. Hyland et al. (33) proposed that because of the separation of the P1 nitrogen from the hydroxyl-bearing tetrahedral carbon by an extra methylene group, the hydroxyethylamine moiety of JG-365 better mimics the transition state for the (rate-limiting) breakdown of the tetrahedral intermediate. By contrast, reduced amide bond inhibitors (such as MVT-101) better mimic the (non-rate-limiting) transition state for the formation of the tetrahedral intermediate (Fig. 4) . If, as transition state theory requires, the backboneengineered enzyme analogue no longer binds the rate-limiting transition state as tightly (relative to the native enzyme), it follows that a mimic of this transition state (JG-365) would not inhibit the analogue enzyme as potently as it does the native enzyme, while inhibition by a mimic of the non-ratelimiting transition state (MVT-101) would remain unchanged (see Fig. 4 ).
In conclusion, we have shown by direct experimental observation that hydrogen bonds between the substrate and the backbone amide bond between Gly49 and Ile50 in each flap of the HIV-1 protease are important for the normal catalytic activity of this enzyme. Whether these hydrogen bonds are mediated by the crystallographically observed water 301, as opposed to direct flap-substrate interactions, remains to be determined. Finally, this study of a functionally relevant backbone-engineered enzyme analogue illustrates the power of the chemical synthesis approach (34) in expanding the scope of exploration of protein structure and function.
